Table 2 Ionization Cluster size distribution and Ion drift time analysis to confirm the breast malignancy.

From: An In-Vitro Study for Early Detection and to Distinguish Breast and Lung Malignancies Using the Pcb Technology Based Nanodosimeter

Parameters/Breast

Without Sample

Normal

Stage 0

Stage 1

Stage 2

Stage 3a

Stage 3b

Stage 4

Ionization Cluster Size Distribution

Range

0–3

713–715

1008–1010

1542–1543

2601–2603

3339–3402

3768–3701

6100–6102

Mean

2.6

714.7

1009.6

1542.8

2602.7

3395.5

3707.7

6101.8

б²

0.84

0.41

0.44

0.16

0.41

0.85

0.81

0.36

б

0.97

0.67

0.67

0.42

0.67

0.97

0.95

0.63

Times

—

—

4.12

11.58

26.41

37.50

41.87

75.37

Ion Drift Time (µs)

Range

6–7

16.3–16.5

41–43

44–46

49–50

61–61.5

90–91

98–99

Mean

6.9

16.47

42.7

45.7

49.9

61.45

90.9

98.9

б²

0.09

0.0041

0.41

0.41

0.09

0.022

0.09

0.09

б

0.32

0.067

0.67

0.67

0.32

0.16

0.32

0.32

Times

—

—

15.92

17.74

20.29

27.31

45.19

50.04

  1. ICSD- Ionization Cluster Size Distribution; IDT- Ion Drift Time; б² - Variance; б - Standard Deviation; NMR – Normal to Malignancy Ratio.
Back to article page